SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-23-000434
Filing Date
2023-09-18
Accepted
2023-09-18 16:02:55
Documents
16
Period of Report
2023-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgbp091823form8k.htm   iXBRL 8-K 29869
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 143315
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 123143
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 133674
5 EXHIBIT 10.4 ex10_4.htm EX-10.4 95129
  Complete submission text file 0001607062-23-000434.txt   829448

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20230912.xsd EX-101.SCH 3254
7 XBRL LABEL FILE rgbp-20230912_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE rgbp-20230912_pre.xml EX-101.PRE 22377
10 EXTRACTED XBRL INSTANCE DOCUMENT rgbp091823form8k_htm.xml XML 3398
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 231261179
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences